CVR: 36893729
DKK -13,668
Gross profit
Net result: DKK -13,668
No owners listed
CVR · view ownership and management
Director role ended: Dres Damgaard
CVR · 11/04/2019
View the full event history
mAbSolution IVS was a Danish company of the type Iværksætterselskab based in Kgs. Lyngby, founded in 2015 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK -13,668 and a net result of DKK -13,668 compared with DKK -7,612 the year before. Equity in the 2017 report amounted to DKK -33,920.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. mAbSolution IVS is registered in the Danish CVR register with the status Dissolved and ceased on 11 April 2019.
mAbSolution IVS was founded on 13 May 2015.
mAbSolution IVS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
In 2017, mAbSolution IVS reported a gross profit of DKK -13,668.
mAbSolution IVS was located at Solvænget 10, 2800 Kgs. Lyngby.
The CVR number of mAbSolution IVS is 36893729.
As of April 11, 2019, Dres Damgaard has stepped down as director of mAbSolution IVS.
As of April 11, 2019, Jørgen Søberg Petersen has stepped down as director of mAbSolution IVS.
As of April 11, 2019, Claus Henrik Nielsen has stepped down as director of mAbSolution IVS.
MAbSolution IVS was dissolved on April 11, 2019.
MAbSolution IVS has published its annual report for 2017. Gross profit came to DKK -13,668, and the net result was DKK -13,668.
As of June 29, 2017, Jørgen Søberg Petersen is registered as director of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen is registered as chairman of mAbSolution IVS.
As of June 29, 2017, Jørgen Søberg Petersen has stepped down as chairman of mAbSolution IVS.
MAbSolution IVS has published its annual report for 2016. Gross profit came to DKK -7,600, and the net result was DKK -7,612.
As of December 7, 2016, Lars Nørgaard has stepped down as director of mAbSolution IVS.
MAbSolution IVS has published its interim report for the period May 13, 2015 – December 31, 2015.
As of May 13, 2015, Dres Damgaard is registered as director of mAbSolution IVS.
As of May 13, 2015, Lars Nørgaard is registered as director of mAbSolution IVS.
As of May 13, 2015, Claus Henrik Nielsen is registered as director of mAbSolution IVS.
MAbSolution IVS was founded on May 13, 2015.
